Medication Repurposing to Stop Cognitive Decline in Dementia

Status Active, not recruiting

Clinical Trial Summary

Dementia creates a great personal and societal burden and there are currently no treatments to stop memory loss. Many patients with dementia take medications to treat other conditions, e.g. high blood pressure and cholesterol. Some of these medications may have central effects on the pathophysiological processes leading to dementia. Medication repurposing is a cost and time-effective way to discover new treatments. Swedish registers are a unique tool to detect medication candidates for repurposing. The Swedish Dementia Registry (SveDem) has >100000 patients and ca. 144000 measures of cognition over time (measured with the Mini-Mental State Examination-MMSE), making it perfect to examine whether certain medications are associated with less cognitive decline in patients with dementia. Cholesterol and kidney function affect treatment and cognition and are available for 25000 patients. The investigators propose a study combining traditional cohort studies and newer artificial intelligence (machine learning) techniques to detect medications associated with slower cognitive decline in patients from SveDem. The investigators will test pre-specified hypotheses since the investigators suspect specific medications are better candidates to prevent cognitive decline, but the investigators will also let the machine learning algorithms explore the data to find associations that the investigators do not suspect in advance. Finally, the candidate medications will be tested in animal and cellular models to determine the mechanisms of their effects.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05817188
Study type	Observational
Source	Karolinska Institutet
Contact
Status	Active, not recruiting
Phase
Start date	January 1, 2023
Completion date	December 31, 2030

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT03255720` - Application of Diffusion Tensor Imaging in Alzheimer's Disease :Quantification of White Matter Micro-structural Changes	N/A
Recruiting	`NCT03507192` - Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia.	N/A
Withdrawn	`NCT05497817` - A Study to Evaluate Caregiver Connections Via Technology for Patients With Alzheimer's and Other Types of Dementia	N/A
Completed	`NCT02317523` - Alzheimer's Caregiver Coping: Mental and Physical Health	N/A
Completed	`NCT03538522` - A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831	Phase 2
Terminated	`NCT03132272` - Immunoadsorption for Treatment of Alzheimer's Disease	N/A
Recruiting	`NCT03275363` - The University of Hong Kong Neurocognitive Disorder Cohort	N/A
Enrolling by invitation	`NCT03724136` - Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study	N/A
Completed	`NCT02267486` - Exploratory Study for the Validity of QuQu Scale	N/A
Active, not recruiting	`NCT03748303` - Allopregnanolone Regenerative Therapeutic for Early Alzheimer's Disease: Intramuscular Study	Phase 1
Completed	`NCT03611439` - Effects of an 8 Component Botanical Supplement on Mild and Moderate Alzheimer's Patients	N/A
Completed	`NCT04058886` - Telephone-delivered Mindfulness Intervention for African American Dementia Caregivers	N/A
Recruiting	`NCT03584568` - Reappraising Intergeneration Relationships in Dementia Caregiving	N/A
Not yet recruiting	`NCT05113732` - Association of Cognition With Functional Mobility in People With Alzheimer's Disease
Completed	`NCT03811847` - A Pilot of Methylphenidate in Mild Cognitive Impairment and Dementia Participants.	Phase 4
Terminated	`NCT03044249` - A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression	Phase 2
Active, not recruiting	`NCT03661034` - Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)	N/A
Completed	`NCT03718494` - Continuation of The Kronos Early Estrogen Prevention Study (KEEPS)
Completed	`NCT03602391` - The Senior Companion Program Plus	N/A
Completed	`NCT03548584` - A Trial to Evaluate the Safety, Efficacy, and Tolerability of Brexpiprazole in Treating Agitation Associated With Dementia of the Alzheimer's Type	Phase 3